Cell activation by CpG ODN leads to improved electrofusion in hybridoma production

Journal of Immunological Methods

Volumn 373, Issue 1-2, 2011, Pages 102-110

  Kato, Mieko ^a,b   Sasamori, Eriko ^a   Chiba, Tomoki ^b   Hanyu, Yoshiro ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Blastogenesis; CpG ODN; Electrofusion; Hybridoma; Luciferase; Monoclonal antibodies

Indexed keywords

ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; CYTOKINE; IMMUNOGLOBULIN G; LUCIFERASE; MACROGOL; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIBODY PRODUCING CELL; ANTIBODY PRODUCTION; ANTIBODY SCREENING; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL DEATH; CELL ISOLATION; CLONE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTROFUSION (CELL); ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; EXPRESSION VECTOR; FEMALE; FLOW CYTOMETRY; HYBRIDOMA; HYBRIDOMA CELL CULTURE; LUMINESCENCE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; CELL FUSION; CELL LINE, TUMOR; CELLS, CULTURED; COPEPODA; CPG ISLANDS; ELECTROCHEMICAL TECHNIQUES; FEMALE; HYBRIDOMAS; LUCIFERASES; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; REPRODUCIBILITY OF RESULTS;

MUS;

EID: 80054835113     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2011.08.008     Document Type: Article

References (32)

1. Baccala R., Hoebe K., Kono D.H., Beutler B., Theofilopoulos A.N. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat. Med. 2007, 13:543.
2. Badr C.E., Hewett J.W., Breakefield X.O., Tannous B.A. A highly sensitive assay for monitoring the secretory pathway and ER stress. PLoS One 2007, 2:e571.
3. Bernasconi N.L., Traggiai E., Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002, 298:2199.
4. Bernasconi N.L., Onai N., Lanzavecchia A. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 2003, 101:4500.
5. Crowe J.E. Recent advances in the study of human antibody responses to influenza virus using optimized human hybridoma approaches. Vaccine 2009, 27(Suppl 6):G47.
6. Davis H.L., Weeratna R., Waldschmidt T.J., Tygrett L., Schorr J., Krieg A.M. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 1998, 160:870.
7. Herman S.E., Gordon A.L., Hertlein E., Ramanunni A., Zhang X., Jaglowski S., Flynn J., Jones J., Blum K.A., Buggy J.J., Hamdy A., Johnson A.J., Byrd J.C. Bruton's tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted. Blood 2011, 117:6287.
8. Inouye S., Sahara Y. Identification of two catalytic domains in a luciferase secreted by the copepod Gaussia princeps. Biochem. Biophys. Res. Commun. 2008, 365:96.
9. Karsten U., Stolley P., Walther I., Papsdorf G., Weber S., Conrad K., Pasternak L., Kopp J. Direct comparison of electric field-mediated and PEG-mediated cell fusion for the generation of antibody producing hybridomas. Hybridoma 1988, 7:627.
10. Kiesel M., Reuss R., Endter J., Zimmermann D., Zimmermann H., Shirakashi R., Bamberg E., Zimmermann U., Sukhorukov V.L. Swelling-activated pathways in human T-lymphocytes studied by cell volumetry and electrorotation. Biophys. J. 2006, 90:4720.
11. Kitagaki K., Jain V.V., Businga T.R., Hussain I., Kline J.N. Immunomodulatory effects of CpG oligodeoxynucleotides on established th2 responses. Clin. Diagn. Lab. Immunol. 2002, 9:1260.
12. Kwekkeboom J., van Oosten M., de Boer M., van Alphen L., Mevissen M.L., Lindhout E., Tager J.M., de Groot C. An efficient procedure for the generation of human monoclonal antibodies based on activation of human B lymphocytes by a murine thymoma cell line. J. Immunol. Methods 1993, 160:117.
13. Larrick J.W., Truitt K.E., Raubitschek A.A., Senyk G., Wang J.C. Characterization of human hybridomas secreting antibody to tetanus toxoid. Proc. Natl. Acad. Sci. U. S. A. 1983, 80:6376.
14. Li L.H., Hui S.W. Characterization of PEG-mediated electrofusion of human erythrocytes. Biophys. J. 1994, 67:2361.
15. Mussauer H., Sukhorukov V.L., Zimmermann U. Trehalose improves survival of electrotransfected mammalian cells. Cytometry 2001, 45:161.
16. Remy I., Michnick S.W. A highly sensitive protein-protein interaction assay based on Gaussia luciferase. Nat. Methods 2006, 3:977.
17. Sanjuan M.A., Rao N., Lai K.T., Gu Y., Sun S., Fuchs A., Fung-Leung W.P., Colonna M., Karlsson L. CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion. J. Cell Biol. 2006, 172:1057.
18. Schmidt E., Leinfelder U., Gessner P., Zillikens D., Brocker E.B., Zimmermann U. CD19+ B lymphocytes are the major source of human antibody-secreting hybridomas generated by electrofusion. J. Immunol. Methods 2001, 255:93.
19. Schmitt J.J., Zimmermann U. Enhanced hybridoma production by electrofusion in strongly hypo-osmolar solutions. Biochim. Biophys. Acta 1989, 983:42.
20. Sukhorukov V.L., Reuss R., Zimmermann D., Held C., Muller K.J., Kiesel M., Gessner P., Steinbach A., Schenk W.A., Bamberg E., Zimmermann U. Surviving high-intensity field pulses: strategies for improving robustness and performance of electrotransfection and electrofusion. J. Membr. Biol. 2005, 206:187.
21. Sukhorukov V.L., Imes D., Woellhaf M.W., Andronic J., Kiesel M., Shirakashi R., Zimmermann U., Zimmermann H. Pore size of swelling-activated channels for organic osmolytes in Jurkat lymphocytes, probed by differential polymer exclusion. Biochim. Biophys. Acta 2009, 1788:1841.
22. Sun C.M., Deriaud E., Leclerc C., Lo-Man R. Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. Immunity 2005, 22:467.
23. Traggiai E., Becker S., Subbarao K., Kolesnikova L., Uematsu Y., Gismondo M.R., Murphy B.R., Rappuoli R., Lanzavecchia A. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat. Med. 2004, 10:871.
24. Verhaegent M., Christopoulos T.K. Recombinant Gaussia luciferase. Overexpression, purification, and analytical application of a bioluminescent reporter for DNA hybridization. Anal. Chem. 2002, 74:4378.
25. Vienken J., Zimmermann U. An improved electrofusion technique for production of mouse hybridoma cells. FEBS Lett. 1985, 182:278.
26. Weeratna R.D., McCluskie M.J., Xu Y., Davis H.L. CpG DNA induces stronger immune responses with less toxicity than other adjuvants. Vaccine 2000, 18:1755.
27. Weeratna R.D., Brazolot Millan C.L., McCluskie M.J., Davis H.L. CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice. FEMS Immunol. Med. Microbiol. 2001, 32:65.
28. Weeratna R., Comanita L., Davis H.L. CPG ODN allows lower dose of antigen against hepatitis B surface antigen in BALB/c mice. Immunol. Cell Biol. 2003, 81:59.
29. Weeratna R.D., Makinen S.R., McCluskie M.J., Davis H.L. TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848). Vaccine 2005, 23:5263.
30. Yoshinari K., Arai K., Kimura H., Matsumoto K., Yamaguchi Y. Efficient production of IgG human monoclonal antibodies by lymphocytes stimulated by lipopolysaccharide, pokeweed mitogen, and interleukin 4. In Vitro Cell Dev. Biol. Anim. 1996, 32:372.
31. Yu X., McGraw P.A., House F.S., Crowe J.E. An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies. J. Immunol. Methods 2008, 336:142.
32. Zimmermann U., Gessner P., Schnettler R., Perkins S., Foung S.K. Efficient hybridization of mouse-human cell lines by means of hypo-osmolar electrofusion. J. Immunol. Methods 1990, 134:43.